Description

Tesamorelin / Ipamorelin 5 mg / 5 mg

Tesamorelin / Ipamorelin is a research peptide blend containing 5 mg Tesamorelin and 5 mg Ipamorelin, providing a total nominal peptide quantity of 10 mg.

The two peptides are studied experimentally in relation to distinct but associated endocrine signalling pathways. Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin is characterised by activity at the growth hormone secretagogue receptor (GHS-R1a).

Benchmark Peptides supplies this peptide blend as a research material for laboratory and analytical use only. This product is not supplied or intended for human or veterinary use.

Product Specifications

• Product: Tesamorelin / Ipamorelin Blend
• Catalogue Reference: TI10
• Composition: 5 mg Tesamorelin + 5 mg Ipamorelin
• Total Quantity: 10 mg
• Physical Form: Lyophilised material
• Appearance: White to off-white
• Grade: Research grade
• Batch: See current batch information
• Analytical Documentation: See current Certificate of Analysis, where available

Research Information

This blend combines two synthetic peptides investigated in relation to growth hormone-associated endocrine signalling and peptide-receptor interactions.

Tesamorelin

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), investigated experimentally in relation to GHRH receptor activity and associated pituitary endocrine signalling mechanisms.

The GHRH receptor is a G-protein-coupled receptor involved in the regulation of growth hormone-associated endocrine pathways.

Research involving Tesamorelin includes investigation of GHRH receptor interactions, downstream cellular signalling and hypothalamic-pituitary regulatory mechanisms.

Ipamorelin

Ipamorelin is a synthetic pentapeptide characterised by activity at the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor.

GHS-R1a is a G-protein-coupled receptor associated with neuroendocrine signalling and growth hormone regulatory mechanisms.

Research involving Ipamorelin includes investigation of receptor binding, intracellular signalling and peptide-mediated endocrine pathways.

Associated Research Pathways

Scientific research involving these peptides and their associated pathways includes investigation of:

• GHRH receptor signalling
• GHS-R1a receptor signalling
• Growth hormone-associated endocrine pathways
• GH/IGF-1 axis physiology
• Hypothalamic-pituitary signalling mechanisms
• Peptide-receptor interactions
• G-protein-coupled receptor signalling
• Pituitary cellular signalling
• Endocrine peptide pharmacology
• Growth hormone secretory patterns

The combination provides a laboratory research material containing two peptides associated with distinct receptor pathways involved in growth hormone regulation.

Research involving the individual compounds should not be interpreted as establishing the properties or biological behaviour of the combined material.

Information provided by Benchmark Peptides is intended solely to identify and characterise the research materials supplied. It should not be interpreted as medical information, treatment guidance or a recommendation for use.

Batch & Quality Information

Batch-specific analytical information is provided through the Certificate of Analysis where available for this product.

Where available, the Certificate of Analysis provides information including:

• Batch identification
• Analytical identity
• Analytical purity
• Testing methodology
• Laboratory information
• Test date and associated analytical data

For peptide blends, analytical documentation should be reviewed with consideration of both components of the supplied material.

Analytical results relate specifically to the identified batch and should not be interpreted as establishing suitability for any particular application.

Storage & Laboratory Handling

Store the sealed research material according to the conditions specified in the applicable product or batch documentation.

For longer-term laboratory storage, protect the material from excessive heat, moisture and direct light, subject to the manufacturer’s documented storage requirements.

Where the material is prepared in solution for legitimate analytical or laboratory work, appropriate preparation, handling and storage conditions should be determined by the researcher’s validated laboratory protocol.

Package Contents

• 1 × Tesamorelin / Ipamorelin research vial
• 5 mg Tesamorelin + 5 mg Ipamorelin
• 10 mg total nominal peptide content
• Sealed closure
• Batch identification

Product Category

Endocrine Research

This material is categorised according to its relevance to experimental research involving GHRH receptor activity, GHS-R1a signalling and growth hormone-associated endocrine regulatory pathways.

Important Notice

FOR RESEARCH USE ONLY

Supplied exclusively as a laboratory research material.

NOT FOR HUMAN OR VETERINARY USE.

Not supplied for administration, diagnosis, treatment, cure or prevention of any disease.

Researchers are responsible for ensuring that acquisition, possession, handling and use comply with all applicable laws, regulations and institutional requirements.